Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23 Hold
13
﹤0.01% 881
2026
Q1
$25 Hold
13
﹤0.01% 855
2025
Q4
$25 Hold
13
﹤0.01% 858
2025
Q3
$11 Hold
13
﹤0.01% 887
2025
Q2
$10 Hold
13
﹤0.01% 874
2025
Q1
$52 Hold
13
﹤0.01% 864
2024
Q4
$32 Hold
13
﹤0.01% 865
2024
Q3
$29 Hold
13
﹤0.01% 829
2024
Q2
$27 Hold
13
﹤0.01% 843
2024
Q1
$53 Hold
13
﹤0.01% 894
2023
Q4
$18 Sell
13
-1
-7% -$4 ﹤0.01% 900
2023
Q3
$82 Hold
14
﹤0.01% 907
2023
Q2
$165 Hold
14
﹤0.01% 886
2023
Q1
$564 Hold
14
﹤0.01% 835
2022
Q4
$120 Hold
14
﹤0.01% 932
2022
Q3
$1K Hold
14
﹤0.01% 772
2022
Q2
$1K Hold
14
﹤0.01% 758
2022
Q1
$2K Hold
14
﹤0.01% 801
2021
Q4
$3K Hold
14
﹤0.01% 726
2021
Q3
$7K Hold
14
﹤0.01% 642
2021
Q2
$10K Hold
14
﹤0.01% 574
2021
Q1
$10K Hold
14
﹤0.01% 514
2020
Q4
$17K Buy
+14
New +$11.4K ﹤0.01% 433

Other funds holding IBIO

SOA Wealth Advisors's IBIO Position: Q2 2026 in Review

SOA Wealth Advisors held its iBio (IBIO) position steady in Q2 2026 at 13 shares worth $23. The position accounts for ﹤0.01% of the portfolio, ranked #881.

SOA Wealth Advisors first reported a position in IBIO in Q4 2020 and has held it in 23 quarters since. The position peaked at $17K in Q4 2020. 10 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • SOA Wealth Advisors held 13 shares of iBio worth $23 as of Q2 2026.
  • SOA Wealth Advisors left its iBio share count unchanged in Q2 2026.
  • iBio made up ﹤0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #881 holding.
  • SOA Wealth Advisors first reported a position in iBio in Q4 2020 and has held it in 23 quarters since.
  • SOA Wealth Advisors's iBio position peaked at $17K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.